Company’s 36-month beta value is -0.07.
The public float for SLXN is 1.66M, and currently, short sellers hold a 13.65% ratio of that floaft. The average trading volume of SLXN on September 16, 2024 was 1.33M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
SLXN) stock’s latest price update
Silexion Therapeutics Corp (NASDAQ: SLXN) has experienced a decline in its stock price by -8.18 compared to its previous closing price of 1.10. However, the company has seen a gain of 15.04% in its stock price over the last five trading days. globenewswire.com reported 2024-09-03 that GRAND CAYMAN, Cayman Island, Sept. 03, 2024 (GLOBE NEWSWIRE) — Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage, oncology-focused biotechnology company today announced that Company management will be attending and presenting at the H.C. Wainwright 26th Annual Global Investment Conference being held September 9-11, 2024 at the Lotte New York Palace Hotel in New York, NY.
SLXN’s Market Performance
Silexion Therapeutics Corp (SLXN) has seen a 15.04% rise in stock performance for the week, with a -90.73% decline in the past month and a -90.86% plunge in the past quarter. The volatility ratio for the week is 22.22%, and the volatility levels for the past 30 days are at 33.66% for SLXN. The simple moving average for the past 20 days is -44.36% for SLXN’s stock, with a -89.70% simple moving average for the past 200 days.
SLXN Trading at -86.90% from the 50-Day Moving Average
After a stumble in the market that brought SLXN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -92.55% of loss for the given period.
Volatility was left at 33.66%, however, over the last 30 days, the volatility rate increased by 22.22%.
During the last 5 trading sessions, SLXN rose by +15.03%, in comparison to the 20-day moving average. In addition, Silexion Therapeutics Corp saw -90.69% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for SLXN
Equity return is now at value -3.78, with -3.13 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.75.
Conclusion
In a nutshell, Silexion Therapeutics Corp (SLXN) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
